PapersFlow Research Brief
Escherichia coli research studies
Research Guide
What is Escherichia coli research studies?
Escherichia coli research studies encompass investigations into the pathogenesis, virulence mechanisms, genomic analysis, Shiga toxin production, bacterial invasion, urinary tract infections, molecular pathogenesis, type III secretion systems, and vaccine development of pathogenic Escherichia coli strains.
This field includes 80,056 papers focused on how Escherichia coli causes diseases such as urinary tract infections and diarrheal illnesses through virulence factors like Shiga toxin and lipopolysaccharide endotoxins. Key studies examine bacterial cell envelope structures and phylogenetic grouping to distinguish pathogenic from nonpathogenic strains. Research also covers immune responses to E. coli components like flagellin and epidemiological burdens in developing countries.
Topic Hierarchy
Research Sub-Topics
Escherichia coli Urinary Tract Infections
This sub-topic investigates uropathogenic E. coli (UPEC) adhesion via type 1 fimbriae, intracellular bacterial communities, and host immune evasion in cystitis and pyelonephritis. Genomic epidemiology and virulence factor prevalence are analyzed.
Shiga Toxin-Producing Escherichia coli
Researchers study STEC O157:H7 toxin production, lambdoid phage integration, and hemolytic uremic syndrome mechanisms. Outbreak investigations link serotypes, virulence plasmids, and foodborne transmission dynamics.
Type III Secretion System in Escherichia coli
This area elucidates EHEC and EPEC injectisome assembly, effector protein translocation, and pedestal formation on host cells. Structural biology and mutant studies reveal intimate adhesion and signaling subversion.
Escherichia coli Genomic Pathogenicity Islands
Studies map horizontally acquired loci like LEE, HPI, and CPAIs encoding adhesins, toxins, and iron acquisition systems. Comparative genomics across pathotypes identifies mobility and evolution drivers.
Vaccine Development against Pathogenic Escherichia coli
Research develops subunit vaccines targeting fimbriae, flagella, and autotransporters for diarrheagenic and extraintestinal E. coli. Preclinical trials assess immunogenicity, protection in animal models, and adjuvant strategies.
Why It Matters
Escherichia coli research studies address major public health challenges by elucidating mechanisms behind urinary tract infections affecting millions annually, as detailed in 'Urinary tract infections: epidemiology, mechanisms of infection and treatment options' (Flores‐Mireles et al., 2015), which identifies uropathogenic E. coli adhesion and invasion strategies for targeted therapies. Studies like 'Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study' (Kotloff et al., 2013) quantify E. coli's role in 3507-cited analysis of diarrheal deaths in infants, informing vaccine development against diarrheagenic strains. 'Hemorrhagic Colitis Associated with a Rare Escherichia coli Serotype' (Riley et al., 1983) linked enterohemorrhagic E. coli O157:H7 to outbreaks, enabling food safety measures that reduced U.S. incidence from thousands of cases yearly.
Reading Guide
Where to Start
'Pathogenic Escherichia coli' by Kaper et al. (2004), as it provides a foundational overview of E. coli virulence mechanisms with 5291 citations, suitable for grasping pathogenesis basics before specifics.
Key Papers Explained
'Pathogenic Escherichia coli' (Kaper et al., 2004) establishes broad virulence frameworks, which 'Diarrheagenic Escherichia coli' (Nataro and Kaper, 1998) expands to gastrointestinal pathogens with 4954 citations. 'Lipopolysaccharide Endotoxins' (Raetz and Whitfield, 2002) details envelope components central to both, cited 4236 times. 'Urinary tract infections: epidemiology, mechanisms of infection and treatment options' (Flores‐Mireles et al., 2015) applies these to UTIs (3932 citations), while 'The Bacterial Cell Envelope' (Silhavy et al., 2010) contextualizes structures enabling invasion.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Focus shifts to epidemiological impacts, as in 'Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study' (Kotloff et al., 2013), and rapid phylogenetic tools from 'Rapid and Simple Determination of the Escherichia coli Phylogenetic Group' (Clermont et al., 2000). No recent preprints or news reported, so prioritize genomic and immune response extensions from top-cited works.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Pathogenic Escherichia coli | 2004 | Nature Reviews Microbi... | 5.3K | ✕ |
| 2 | Diarrheagenic<i>Escherichia coli</i> | 1998 | Clinical Microbiology ... | 5.0K | ✓ |
| 3 | Lipopolysaccharide Endotoxins | 2002 | Annual Review of Bioch... | 4.2K | ✓ |
| 4 | Urinary tract infections: epidemiology, mechanisms of infectio... | 2015 | Nature Reviews Microbi... | 3.9K | ✓ |
| 5 | The innate immune response to bacterial flagellin is mediated ... | 2001 | Nature | 3.5K | ✕ |
| 6 | The Bacterial Cell Envelope | 2010 | Cold Spring Harbor Per... | 3.5K | ✓ |
| 7 | Burden and aetiology of diarrhoeal disease in infants and youn... | 2013 | The Lancet | 3.5K | ✕ |
| 8 | Hemorrhagic Colitis Associated with a Rare<i>Escherichia coli<... | 1983 | New England Journal of... | 2.6K | ✕ |
| 9 | Rapid and Simple Determination of the <i>Escherichia coli</i> ... | 2000 | Applied and Environmen... | 2.6K | ✓ |
| 10 | Bifidobacteria can protect from enteropathogenic infection thr... | 2011 | Nature | 2.3K | ✕ |
Frequently Asked Questions
What are the main pathogenic types of Escherichia coli?
Pathogenic Escherichia coli strains cause gastrointestinal, urinary, or central nervous system diseases, as outlined in 'Pathogenic Escherichia coli' (Kaper et al., 2004) with 5291 citations. 'Diarrheagenic Escherichia coli' (Nataro and Kaper, 1998) details categories like enteropathogenic and enterohemorrhagic types responsible for diarrhea. These strains differ from nonpathogenic intestinal flora by acquiring virulence factors such as Shiga toxin.
How do lipopolysaccharide endotoxins contribute to E. coli virulence?
Lipopolysaccharide (LPS) in E. coli consists of lipid A endotoxin, core oligosaccharide, and O-antigen, triggering immune responses, per 'Lipopolysaccharide Endotoxins' (Raetz and Whitfield, 2002) with 4236 citations. Genomic data reveal LPS assembly variations across Gram-negative bacteria. LPS protects bacteria from host defenses while provoking inflammation in infections.
What methods determine E. coli phylogenetic groups?
'Rapid and Simple Determination of the Escherichia coli Phylogenetic Group' (Clermont et al., 2000) introduces a PCR-based assay distinguishing groups A, B1, B2, and D, cited 2579 times. Virulent extra-intestinal strains predominantly belong to B2 and D groups. This triplex PCR replaces complex electrophoresis or ribotyping for quick classification.
What role does flagellin play in immune recognition of E. coli?
The innate immune response to E. coli flagellin occurs via Toll-like receptor 5, as shown in 'The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5' (Hayashi et al., 2001) with 3529 citations. Flagellin detection activates signaling pathways in host cells. This mechanism underlies inflammatory responses to motile pathogens.
How does the bacterial cell envelope aid E. coli pathogenesis?
The Gram-negative E. coli envelope includes an outer membrane, thin peptidoglycan wall, and inner membrane, providing protection, according to 'The Bacterial Cell Envelope' (Silhavy et al., 2010) with 3507 citations. This structure enables virulence through secretion systems and endotoxin release. Envelope components like LPS are central to immune evasion and invasion.
What is the burden of E. coli diarrheal disease?
'Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study' (Kotloff et al., 2013) identifies E. coli as a leading cause in infants across seven countries. The GEMS study links specific strains to severe cases and mortality. Findings guide interventions in high-burden regions.
Open Research Questions
- ? How do type III secretion systems in uropathogenic E. coli evade host immune responses during urinary tract colonization?
- ? What genomic variations enable Shiga toxin-producing E. coli to cause hemorrhagic colitis beyond serotype O157:H7?
- ? Can acetate production by Bifidobacteria be harnessed to block enteropathogenic E. coli adhesion in the gut microbiome?
- ? Which phylogenetic group shifts in extraintestinal E. coli promote antibiotic resistance in urinary tract infections?
- ? How do interactions between E. coli LPS core structures and host Toll-like receptors modulate inflammation outcomes?
Recent Trends
The field comprises 80,056 works with no specified 5-year growth rate; foundational papers like 'Pathogenic Escherichia coli' (Kaper et al., 2004, 5291 citations) and 'Diarrheagenic Escherichia coli' (Nataro and Kaper, 1998, 4954 citations) remain most cited.
No recent preprints or news coverage in the last 12 months indicates steady reliance on established studies in pathogenesis and UTIs.
Emphasis persists on Shiga toxin and genomic analysis without new shifts.
Research Escherichia coli research studies with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Escherichia coli research studies with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers